Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial December 1, 2016
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future December 1, 2016
Ketamine’s Mechanisms of Rapid Antidepressant Activity: Evidence from Preclinical Studies November 30, 2016
Integrative analysis of sex differences in the rapid antidepressant effects of ketamine in preclinical models for individualized clinical outcomes November 26, 2016
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology November 23, 2016
Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects November 21, 2016
